文献速递血管炎

ANCA相关血管炎的全因与病因特异性死亡率:总体及按ANCA类型分析

All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究基于2002至2017年Partners HealthCare系统中484例新诊断ANCA相关血管炎患者,随访3385人年,130例死亡,死亡率38.4/1000人年,标准化死亡比(SMR)2.3(95%CI:1.9,2.8)。最常见死因为心血管疾病(累积发生率7.1%)、恶性肿瘤(5.9%)和感染(4.1%)。MPO-ANCA阳性患者心血管死亡风险显著高于PR3-ANCA阳性患者[风险比5.0(95%CI:1.2,21.2),P=0.03]。

要点

  • ANCA相关血管炎患者总体死亡率显著高于一般人群,SMR为2.3。
  • 感染相关的超额死亡风险最高,MPO-ANCA阳性SMR 16.4,PR3-ANCA阳性SMR 6.5。
  • MPO-ANCA阳性患者心血管死亡风险是PR3-ANCA阳性患者的5.0倍。

核心结论

  • ANCA相关血管炎的过早死亡由心血管疾病、感染、恶性肿瘤和肾脏疾病所致。
  • 心血管疾病是最常见死因,但感染导致的超额死亡风险最大。
  • MPO-ANCA阳性患者心血管死亡风险高于PR3-ANCA阳性患者。

研究设计与样本

  • 研究为连续起始队列,纳入2002至2017年Partners HealthCare系统新诊断的ANCA相关血管炎患者484例。
  • 通过国家死亡索引确定生存状态,计算累积死亡率和标准化死亡比(SMR),并用Cox回归比较MPO与PR3-ANCA阳性病例。

主要发现

  • 队列平均诊断年龄58岁,40%为男性,65%为MPO-ANCA阳性,65%有肾脏受累。
  • 随访3385人年期间130例死亡,死亡率为38.4/1000人年,SMR为2.3(95%CI:1.9,2.8)。
  • 最常见死因为心血管疾病(累积发生率7.1%)、恶性肿瘤(5.9%)和感染(4.1%)。

关键数值与推荐

  • 感染SMR在MPO-ANCA阳性患者为16.4,在PR3-ANCA阳性患者为6.5。
  • MPO-ANCA阳性患者心血管疾病SMR为3.0,呼吸系统疾病SMR为2.4,肾脏疾病SMR为4.5。
  • PR3-ANCA阳性患者恶性肿瘤SMR为3.7,MPO-ANCA阳性患者为2.7。
  • 与PR3-ANCA阳性患者相比,MPO-ANCA阳性患者心血管死亡风险比5.0(95%CI:1.2,21.2),P=0.03。

临床怎么用

  • 临床应重视ANCA相关血管炎患者的心血管疾病、感染和恶性肿瘤筛查与管理。
  • 对MPO-ANCA阳性患者需特别关注心血管死亡风险。
  • 感染是超额死亡的主要驱动因素,应加强感染预防和监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to evaluate causes of death in a contemporary inception cohort of ANCA-associated vasculitis patients, stratifying the analysis according to ANCA type. METHODS: We identified a consecutive inception cohort of patients newly diagnosed with ANCA-associated vasculitis from 2002 to 2017 in the Partners HealthCare System and determined vital status through the National Death Index. We determined cumulative mortality incidence and standardized mortality ratios (SMRs) compared with the general population. We compared MPO- and PR3-ANCA+ cases using Cox regression models. RESULTS: The cohort included 484 patients with a mean diagnosis age of 58 years; 40% were male, 65% were MPO-ANCA+, and 65% had renal involvement. During 3385 person-years (PY) of follow-up, 130 patients died, yielding a mortality rate of 38.4/1000 PY and a SMR of 2.3 (95% CI: 1.9, 2.8). The most common causes of death were cardiovascular disease (CVD; cumulative incidence 7.1%), malignancy (5.9%) and infection (4.1%). The SMR for infection was greatest for both MPO- and PR3-ANCA+ patients (16.4 and 6.5). MPO-ANCA+ patients had an elevated SMR for CVD (3.0), respiratory disease (2.4) and renal disease (4.5). PR3- and MPO-ANCA+ patients had an elevated SMR for malignancy (3.7 and 2.7). Compared with PR3-ANCA+ patients, MPO-ANCA+ patients had a higher risk of CVD death [hazard ratio 5.0 (95% CI: 1.2, 21.2]; P = 0.03]. CONCLUSION: Premature ANCA-associated vasculitis mortality is explained by CVD, infection, malignancy, and renal death. CVD is the most common cause of death, but the largest excess mortality risk in PR3- and MPO-ANCA+ patients is associated with infection. MPO-ANCA+ patients are at higher risk of CVD death than PR3-ANCA+ patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wallace ZS, Fu X, Harkness T, et al. All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology (Oxford). 2020. PMID: 31846030. doi:10.1093/rheumatology/kez589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。